MedTrace Logo

The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake

NCT07320157 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-01-22

No results posted yet for this study

Summary

Type of Study: This study was planned to be an observational study.

Purpose of the Study: To evaluate the impact of HPV education given to women on their knowledge levels and HPV screening and vaccination.The main question\[s\] it aims to answer \[is/are\]:

H1: There is a difference in the mean Human Papillomavirus (HPV) Knowledge Scale score between the intervention group women who participated in Human Papillomavirus (HPV) education and the control group women.

H2: There is a difference between the intervention group women and the control group women in terms of their participation in HPV screening tests.

H2: There is a difference between the intervention group women and the control group women in terms of their HPV vaccination status.

Participants Participants will be assigned to a control and intervention group. Online training will be provided to the intervention group, and the results of the training will be reported.

Conditions

  • HPV (Human Papillomavirus)-Associated
  • HPV Immunization Status

Interventions

BEHAVIORAL

Online Education Intervention Group

An online training session will be scheduled for the intervention group. The training will consist of two 40-minute session. After the online training, the training materials will be shared with the group. One week after the training, an informational brochure prepared on the topic will be sent to the intervention group via WhatsApp as a reminder, and any questions they may have will be answered. Two weeks after delivering the brochure, the questionnaire/scale forms will be administered to both groups as the first follow-up. Eight weeks after the first follow-up, the same forms will be administered again as the post-test. The WhatsApp group will remain open and interaction will be allowed throughout the research period.

OTHER

Contral Group

No intervention will be applied to the control group. Following the completion of the study, the brochure prepared on the topic will be sent to them via WhatsApp.

Sponsors & Collaborators

  • Ufuk University

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-09
Primary Completion
2026-01-23
Completion
2026-04-03

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07320157 on ClinicalTrials.gov